188 related articles for article (PubMed ID: 26313682)
1. Refining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools.
Mahar AL; Compton C; McShane LM; Halabi S; Asamura H; Rami-Porta R; Groome PA;
J Thorac Oncol; 2015 Nov; 10(11):1576-89. PubMed ID: 26313682
[TBL] [Abstract][Full Text] [Related]
2. Critical Assessment of Clinical Prognostic Tools in Melanoma.
Mahar AL; Compton C; Halabi S; Hess KR; Gershenwald JE; Scolyer RA; Groome PA
Ann Surg Oncol; 2016 Sep; 23(9):2753-61. PubMed ID: 27052645
[TBL] [Abstract][Full Text] [Related]
3. Survival prediction tools for esophageal and gastroesophageal junction cancer: A systematic review.
Gupta V; Coburn N; Kidane B; Hess KR; Compton C; Ringash J; Darling G; Mahar AL
J Thorac Cardiovasc Surg; 2018 Aug; 156(2):847-856. PubMed ID: 30011772
[TBL] [Abstract][Full Text] [Related]
4. Decision making in surgical treatment of chronic low back pain: the performance of prognostic tests to select patients for lumbar spinal fusion.
Willems P
Acta Orthop Suppl; 2013 Feb; 84(349):1-35. PubMed ID: 23427903
[TBL] [Abstract][Full Text] [Related]
5. Prognosis in lung cancer: physicians' opinions compared with outcome and a predictive model.
Muers MF; Shevlin P; Brown J
Thorax; 1996 Sep; 51(9):894-902. PubMed ID: 8984699
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer.
Liang W; Zhang L; Jiang G; Wang Q; Liu L; Liu D; Wang Z; Zhu Z; Deng Q; Xiong X; Shao W; Shi X; He J
J Clin Oncol; 2015 Mar; 33(8):861-9. PubMed ID: 25624438
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in non-small cell lung cancer: a decade of progress.
Brundage MD; Davies D; Mackillop WJ
Chest; 2002 Sep; 122(3):1037-57. PubMed ID: 12226051
[TBL] [Abstract][Full Text] [Related]
8. Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.
Louie AV; Haasbeek CJ; Mokhles S; Rodrigues GB; Stephans KL; Lagerwaard FJ; Palma DA; Videtic GM; Warner A; Takkenberg JJ; Reddy CA; Maat AP; Woody NM; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):82-90. PubMed ID: 26138912
[TBL] [Abstract][Full Text] [Related]
9. Establishment of an Adjusted Prognosis Analysis Model for Initially Diagnosed Non-Small-Cell Lung Cancer With Brain Metastases From Sun Yat-Sen University Cancer Center.
Dinglin XX; Ma SX; Wang F; Li DL; Liang JZ; Chen XR; Liu Q; Zeng YD; Chen LK
Clin Lung Cancer; 2017 May; 18(3):e179-e186. PubMed ID: 28185793
[TBL] [Abstract][Full Text] [Related]
10. Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes.
Mahar AL; Compton C; Halabi S; Hess KR; Weiser MR; Groome PA
J Surg Oncol; 2017 Dec; 116(8):969-982. PubMed ID: 28767139
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode.
Birim O; Kappetein AP; Waleboer M; Puvimanasinghe JP; Eijkemans MJ; Steyerberg EW; Versteegh MI; Bogers AJ
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):491-8. PubMed ID: 16935100
[TBL] [Abstract][Full Text] [Related]
12. 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index.
Blanchon F; Grivaux M; Asselain B; Lebas FX; Orlando JP; Piquet J; Zureik M
Lancet Oncol; 2006 Oct; 7(10):829-36. PubMed ID: 17012045
[TBL] [Abstract][Full Text] [Related]
13. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
14. Applying the QUARTZ Trial Results in Clinical Practice: Development of a Prognostic Model Predicting Poor Outcomes for Non-small Cell Lung Cancers with Brain Metastases.
Agarwal JP; Chakraborty S; Laskar SG; Mummudi N; Patil VM; Upasani M; Prabhash K; Noronha V; Joshi A; Purandare N; Tandon S; Arora J; Badhe R
Clin Oncol (R Coll Radiol); 2018 Jun; 30(6):382-390. PubMed ID: 29499878
[TBL] [Abstract][Full Text] [Related]
15. A Prognostic Instrument to Estimate the Survival of Elderly Patients Irradiated for Metastatic Epidural Spinal Cord Compression From Lung Cancer.
Rades D; Conde-Moreno AJ; Segedin B; Veninga T; Cacicedo J; Schild SE
Clin Lung Cancer; 2016 Jul; 17(4):279-84. PubMed ID: 26597378
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in patients with spinal metastasis: a systematic review and meta-analysis.
Luksanapruksa P; Buchowski JM; Hotchkiss W; Tongsai S; Wilartratsami S; Chotivichit A
Spine J; 2017 May; 17(5):689-708. PubMed ID: 27988342
[TBL] [Abstract][Full Text] [Related]
17. Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity.
Campbell JM; Raymond E; O'Callaghan ME; Vincent AD; Beckmann KR; Roder D; Evans S; McNeil J; Millar J; Zalcberg J; Borg M; Moretti KL
Clin Genitourin Cancer; 2017 Oct; 15(5):e827-e834. PubMed ID: 28666689
[TBL] [Abstract][Full Text] [Related]
18. Gene expression-based prognostic signatures in lung cancer: ready for clinical use?
Subramanian J; Simon R
J Natl Cancer Inst; 2010 Apr; 102(7):464-74. PubMed ID: 20233996
[TBL] [Abstract][Full Text] [Related]
19. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
